Literature DB >> 23106693

Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats.

Ying Fan1, Shusen Yang, Xiukun Zhang, Yang Cao, Yonglin Huang.   

Abstract

The aim of the present study was to investigate whether the combination of acute or chronic atorvastatin treatment with ischaemic post-conditioning (IPost) exerts differential effects within the hearts of diabetic and non-diabetic rats. Diabetic and non-diabetic rats were randomly assigned to one of six groups: (i) a non-conditioned group; (ii) a group subjected to IPost; (iii) acute statin treatment (50 μmol/L atorvastatin during reperfusion) without IPost; (iv) acute statin treatment plus IPost; (v) chronic statin treatment (10 mg/kg atorvastatin per day for 2 weeks) without IPost; and (vi) chronic statin treatment plus IPost. The hearts from rats in each group were subjected to 30 min global ischaemia, followed by 120 min reperfusion. Infarct size, haemodynamics and Akt and endothelial nitric oxide synthase (eNOS) expression were examined. In hearts from diabetic rats, IPost did not limit infarct size or recover contractile dysfunction. Acute atorvastatin treatment with IPost limited infarct size and recovered contractile dysfunction in hearts from both diabetic and non-diabetic rats and further activated Akt and eNOS signalling pathways to enhance these protective effects in hearts from diabetic rats. Chronic statin treatment with IPost neither reduced infarct size nor increased recovery of myocardial dysfunction in hearts from both diabetic and non-diabetic rats; this may be associated with inhibition of Akt and eNOS phosphorylation. The combination of acute atorvastatin treatment with IPost had a greater protective effect within hearts from diabetic rats, but chronic statin treatment with IPost failed to protect against reperfusion injury in hearts from either diabetic or non-diabetic rats. These findings will be important for the design of future clinical investigations.
© 2012 The Authors Clinical and Experimental Pharmacology and Physiology © 2012 Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23106693     DOI: 10.1111/1440-1681.12014

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  9 in total

1.  In vitro Models of Ischemia-Reperfusion Injury.

Authors:  Timothy Chen; Gordana Vunjak-Novakovic
Journal:  Regen Eng Transl Med       Date:  2018-05-10

Review 2.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

3.  Understanding pacing postconditioning-mediated cardiac protection: a role of oxidative stress and a synergistic effect of adenosine.

Authors:  Fawzi A Babiker; Aishah Al-Jarallah; Shaji Joseph
Journal:  J Physiol Biochem       Date:  2016-11-19       Impact factor: 4.158

Review 4.  Ischemic conditioning: the challenge of protecting the diabetic heart.

Authors:  Joseph Wider; Karin Przyklenk
Journal:  Cardiovasc Diagn Ther       Date:  2014-10

5.  The importance of clinically relevant background therapy in cardioprotective studies.

Authors:  Zhenhe He; Sean M Davidson; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2020-11-13       Impact factor: 17.165

Review 6.  Potential Alteration of Statin-Related Pharmacological Features in Diabetes Mellitus.

Authors:  Habibeh Mashayekhi-Sardoo; Stephen L Atkin; Fabrizio Montecucco; Amirhossein Sahebkar
Journal:  Biomed Res Int       Date:  2021-03-26       Impact factor: 3.411

Review 7.  Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration.

Authors:  J A Epps; N A Smart
Journal:  Cardiovasc Diabetol       Date:  2016-09-09       Impact factor: 9.951

8.  Acute atorvastatin treatment restores the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats.

Authors:  Tao Sun; Hong-Ju Zhang; Chayakrit Krittanawong; Su Wang; Ying Tao; Zhao Li; Qiancheng Yin; Donghua Zhang; Qian Wang; Ji Huang; Jingmei Zhang; Zhizhong Li; Yutong Cheng
Journal:  Oncotarget       Date:  2017-07-14

Review 9.  Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications.

Authors:  Sebastian Roth; Carolin Torregroza; Katharina Feige; Benedikt Preckel; Markus W Hollmann; Nina C Weber; Ragnar Huhn
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.